One bold mission

to make blood speak by solving AI cytometry

Every person should get the right diagnosis and optimal treatment for their unique immune system. We are a committed team of competent people making that dream a reality. We do this by solving AI cytometry, data that holds the the key to the immune system.

Today's imprecision immune medicine 

There's a 30% probability you will suffer a life-altering immune disease, but today, we shoot in the dark when it comes to immune disease.

This causes trillions of healthcare waste and millions of people getting suboptimal treatment every year.

Will you get disease?

When?

How should you be treated?

Today, we shoot in the dark.

The answers are in your blood

Blood is a unique window in your immune system, and cytometry is the globally scaled hardware platform to assess the immune state of your immune system.

Cytometry holds the potential to identify the right treatment at the right time for your unique immune system.

Making blood speak

We have deployed a breakthrough product for AI-assisted diagnosis & reporting of leukemia and lymphoma.

But that's just the beginning: starting with AI clinical cytometry, we are starting a data/distribution flywheel with already the world's most comprehensive database (600k+ files from 20+ centers). What new biology will we uncover if algorithms see more immune systems than any human ever has?

Our newest algorithms are already able to detect second and smaller cancers at superhuman rate, a sneak peak into the future of digital precision medicine.

I would love to talk to you about helping us enable the future of immune medicine

Together with my cofounders, I am motivated to build something huge and have a lasting impact. I'm always happy to talk to investors who want to learn more about this outsized investment opportunity to build the category-leader for AI cytometry.

CEO, founder

Dr. Karsten Miermans